Hypoxia with (18)F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography ((18)F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome

Hypoxia is a well-recognized biological characteristic to therapy resistance and negative prognostic factor in patients with head and neck squamous cell carcinoma (HNSCC). This study aims to investigate the changes of hypoxia measured by (18)F-fluoroerythronitroimidazole (FETNIM) uptake on integrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Man, Xie, Peng, Lee, Nancy Y., Li, Min, Ho, Felix, Lian, Ming, Zhao, Shuqiang, Yang, Guoren, Fu, Zheng, Zheng, Jinsong, Ma, Li, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783245/
https://www.ncbi.nlm.nih.gov/pubmed/31577699
http://dx.doi.org/10.1097/MD.0000000000017067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783245/
https://www.ncbi.nlm.nih.gov/pubmed/31577699
http://dx.doi.org/10.1097/MD.0000000000017067

Ejemplares similares